These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 37189453)
21. Therapeutic Effects of Cold Atmospheric Plasma on Solid Tumor. Min T; Xie X; Ren K; Sun T; Wang H; Dang C; Zhang H Front Med (Lausanne); 2022; 9():884887. PubMed ID: 35646968 [TBL] [Abstract][Full Text] [Related]
23. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. Zhang X; Lao M; Xu J; Duan Y; Yang H; Li M; Ying H; He L; Sun K; Guo C; Chen W; Jiang H; Zhang X; Bai X; Liang T J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35260434 [TBL] [Abstract][Full Text] [Related]
24. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1. Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721 [TBL] [Abstract][Full Text] [Related]
25. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928 [TBL] [Abstract][Full Text] [Related]
26. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1. D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001 [TBL] [Abstract][Full Text] [Related]
27. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice. Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956 [TBL] [Abstract][Full Text] [Related]
28. Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine. Hassannia H; Ghasemi Chaleshtari M; Atyabi F; Nosouhian M; Masjedi A; Hojjat-Farsangi M; Namdar A; Azizi G; Mohammadi H; Ghalamfarsa G; Sabz G; Hasanzadeh S; Yousefi M; Jadidi-Niaragh F Immunology; 2020 Jan; 159(1):75-87. PubMed ID: 31587253 [TBL] [Abstract][Full Text] [Related]
29. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy. Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739 [TBL] [Abstract][Full Text] [Related]
30. Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses. Lan Y; Yeung TL; Huang H; Wegener AA; Saha S; Toister-Achituv M; Jenkins MH; Chiu LY; Lazorchak A; Tarcic O; Wang H; Qi J; Locke G; Kalimi D; Qin G; Marelli B; Yu H; Gross AW; Derner MG; Soloviev M; Botte M; Sircar A; Ma H; Sood VD; Zhang D; Jiang F; Lo KM J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858707 [TBL] [Abstract][Full Text] [Related]
31. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model. Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238 [TBL] [Abstract][Full Text] [Related]
32. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141 [TBL] [Abstract][Full Text] [Related]
33. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy. Lin X; Zeng T; Lin J; Zhang Q; Cheng H; Fang S; Lin S; Chen Y; Xu Y; Lin J Cancer Biol Ther; 2020; 21(2):130-138. PubMed ID: 31690181 [TBL] [Abstract][Full Text] [Related]
34. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. Nesbitt H; Logan K; Thomas K; Callan B; Gao J; McKaig T; Taylor M; Love M; Stride E; McHale AP; Callan JF Cancer Lett; 2021 Oct; 517():88-95. PubMed ID: 34119606 [TBL] [Abstract][Full Text] [Related]
35. Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1. Roux C; Jafari SM; Shinde R; Duncan G; Cescon DW; Silvester J; Chu MF; Hodgson K; Berger T; Wakeham A; Palomero L; Garcia-Valero M; Pujana MA; Mak TW; McGaha TL; Cappello P; Gorrini C Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4326-4335. PubMed ID: 30770442 [TBL] [Abstract][Full Text] [Related]
36. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics. Han X; Li H; Zhou D; Chen Z; Gu Z Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988 [TBL] [Abstract][Full Text] [Related]
37. Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma. Sugii N; Matsuda M; Okumura G; Shibuya A; Ishikawa E; Kaneda Y; Matsumura A Cancer Sci; 2021 Jan; 112(1):81-90. PubMed ID: 33155337 [TBL] [Abstract][Full Text] [Related]
38. Antitumor Effect of Korean Red Ginseng through Blockade of PD-1/PD-L1 Interaction in a Humanized PD-L1 Knock-In MC38 Cancer Mouse Model. Lee EJ; Yang JH; Yang HJ; Cho CK; Choi JG; Chung HS Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768213 [TBL] [Abstract][Full Text] [Related]
39. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. Deng L; Liang H; Burnette B; Beckett M; Darga T; Weichselbaum RR; Fu YX J Clin Invest; 2014 Feb; 124(2):687-95. PubMed ID: 24382348 [TBL] [Abstract][Full Text] [Related]